Identifying patient-specific response to cancer immunotherapy is urgently needed to maximize therapeutic benefit for as many people as possible.

Identifying patient-specific response to cancer immunotherapy is urgently needed to maximize therapeutic benefit for as many people as possible.
Antibiotic-resistant bacteria are becoming a major global threat. Novel antibacterial nanomaterials offer a solution.
Researchers publish detailed protocol on their new antibody test to be used by researchers and clinicians around the world.
A platform with a unique hierarchical nanoridge-in-microridge structure supports the rapid growth of neural cells.
Hyperspectral imaging has the potential to better detect skin cancer to improve the survival rates of patients.
Researchers at the University of Munich have demonstrated a conceptually novel nanocarrier strategy in which the nanoparticles are both the cargo and the carrier.
A new AI system can identify optimal combinations of drugs and dosages in a matter of days to help halt viral pandemics before they reach global scales.
Remdesivir, an anti-viral agent known to be effective against MERS, is already in human trials as researchers search for a treatment for COVID-19.
A nanocarrier that can deliver siRNA into the lungs is investigated for the treatment of severe asthma and other lung diseases.
RNA elements that are found in the genomes of numerous representatives within the same virus family provide new opportunities to expand the repertoire of targets for the development of antiviral therapy.